123 related articles for article (PubMed ID: 16414249)
1. Antipsychotic type and correlates of antipsychotic treatment discontinuation in the outpatient treatment of schizophrenia.
Haro JM; Novick D; Belger M; Jones PB
Eur Psychiatry; 2006 Jan; 21(1):41-7. PubMed ID: 16414249
[TBL] [Abstract][Full Text] [Related]
2. Three-year antipsychotic effectiveness in the outpatient care of schizophrenia: observational versus randomized studies results.
Haro JM; Suarez D; Novick D; Brown J; Usall J; Naber D;
Eur Neuropsychopharmacol; 2007 Mar; 17(4):235-44. PubMed ID: 17137759
[TBL] [Abstract][Full Text] [Related]
3. The SOHO (Schizophrenia Outpatient Health Outcome) study: implications for the treatment of schizophrenia.
Haro JM; Salvador-Carulla L
CNS Drugs; 2006; 20(4):293-301. PubMed ID: 16599647
[TBL] [Abstract][Full Text] [Related]
4. The Schizophrenia Outpatient Health Outcomes (SOHO) study: 3-year results of antipsychotic treatment discontinuation and related clinical factors in Spain.
Ciudad A; Haro JM; Alonso J; Bousoño M; Suárez D; Novick D; Gilaberte I
Eur Psychiatry; 2008 Jan; 23(1):1-7. PubMed ID: 18023154
[TBL] [Abstract][Full Text] [Related]
5. Recovery in the outpatient setting: 36-month results from the Schizophrenia Outpatients Health Outcomes (SOHO) study.
Novick D; Haro JM; Suarez D; Vieta E; Naber D
Schizophr Res; 2009 Mar; 108(1-3):223-30. PubMed ID: 19070991
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of antipsychotic treatment for schizophrenia: 6-month results of the Pan-European Schizophrenia Outpatient Health Outcomes (SOHO) study.
Haro JM; Edgell ET; Novick D; Alonso J; Kennedy L; Jones PB; Ratcliffe M; Breier A;
Acta Psychiatr Scand; 2005 Mar; 111(3):220-31. PubMed ID: 15701107
[TBL] [Abstract][Full Text] [Related]
7. Overview of the findings from the European SOHO study.
Suarez D; Haro JM
Expert Rev Neurother; 2008 Jun; 8(6):873-80. PubMed ID: 18505352
[TBL] [Abstract][Full Text] [Related]
8. Use of concomitant medication with antipsychotic treatment in outpatients with schizophrenia: results from the European Schizophrenia Outpatients Health Outcomes (SOHO) study.
Novick D; Bousono M; Suarez D; Olivares JM; Montejo AL; Haro JM; Edgell ET; Ratcliffe M;
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):972-82. PubMed ID: 16023776
[TBL] [Abstract][Full Text] [Related]
9. Tolerability of outpatient antipsychotic treatment: 36-month results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study.
Novick D; Haro JM; Perrin E; Suarez D; Texeira JM
Eur Neuropsychopharmacol; 2009 Aug; 19(8):542-50. PubMed ID: 19500949
[TBL] [Abstract][Full Text] [Related]
10. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.
Lewis SW; Davies L; Jones PB; Barnes TR; Murray RM; Kerwin R; Taylor D; Hayhurst KP; Markwick A; Lloyd H; Dunn G
Health Technol Assess; 2006 May; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074
[TBL] [Abstract][Full Text] [Related]
11. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
István S; Agoston T; Tamás T; Zoltán J
Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029
[TBL] [Abstract][Full Text] [Related]
12. [Pharmaco-epidemiological study on antipsychotic drug prescription in French Psychiatry: Patient characteristics, antipsychotic treatment, and care management for schizophrenia].
Brunot A; Lachaux B; Sontag H; Casadebaig F; Philippe A; Rouillon F; Cléry-Melin P; Hergueta T; Llorca PM; Moreaudefarges T; Guillon P; Lebrun T
Encephale; 2002; 28(2):129-38. PubMed ID: 11972139
[TBL] [Abstract][Full Text] [Related]
13. [The European schizophrenia outpatient health outcomes (SOHO) study: baseline findings of the Spanish sample].
Ciudad A; Prieto L; Olivares JM; Montejo AL; Ros S; Novick D;
Actas Esp Psiquiatr; 2004; 32(4):227-35. PubMed ID: 15232752
[TBL] [Abstract][Full Text] [Related]
14. Antipsychotic treatment discontinuation in previously untreated patients with schizophrenia: 36-month results from the SOHO study.
Haro JM; Novick D; Suarez D; Roca M
J Psychiatr Res; 2009 Jan; 43(3):265-73. PubMed ID: 18644606
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
Dossenbach M; Erol A; el Mahfoud Kessaci M; Shaheen MO; Sunbol MM; Boland J; Hodge A; O'Halloran RA; Bitter I;
J Clin Psychiatry; 2004 Mar; 65(3):312-21. PubMed ID: 15096069
[TBL] [Abstract][Full Text] [Related]
16. Worldwide-Schizophrenia Outpatient Health Outcomes (W-SOHO): baseline characteristics of pan-regional observational data from more than 17,000 patients.
Karagianis J; Novick D; Pecenak J; Haro JM; Dossenbach M; Treuer T; Montgomery W; Walton R; Lowry AJ
Int J Clin Pract; 2009 Nov; 63(11):1578-88. PubMed ID: 19780867
[TBL] [Abstract][Full Text] [Related]
17. [The intercontinental schizophrenia outpatient health outcomes study (IC-SOHO): initial 6 month findings of the sample in Latin America].
Brunner E; Gargoloff P; Caro O; González C; Landa E; González CH; Barahona A; Soria D; Tamayo J; Rovner J; Adrianzen C; Silva H; Hodge A; O'Halloran R; Assunção SS;
Actas Esp Psiquiatr; 2006; 34(1):16-27. PubMed ID: 16525901
[TBL] [Abstract][Full Text] [Related]
18. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.
Dossenbach M; Pecenak J; Szulc A; Irimia V; Anders M; Logozar-Perkovic D; Peciukaitiene D; Kotler M; Smulevich AB; West TM; Lowry AJ; Treuer T
J Clin Psychiatry; 2008 Dec; 69(12):1901-15. PubMed ID: 19012820
[TBL] [Abstract][Full Text] [Related]
19. Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: a randomized, double-blind, flexible-dose, multicenter study.
Perkins DO; Gu H; Weiden PJ; McEvoy JP; Hamer RM; Lieberman JA;
J Clin Psychiatry; 2008 Jan; 69(1):106-13. PubMed ID: 18312044
[TBL] [Abstract][Full Text] [Related]
20. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
Krzystanek M; Krupka-Matuszczyk I
Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
